The association between ROS1 rearrangement and risk of thromboembolic events in patients with advanced non-small cell lung cancer: a multicenter study in China

Abstract Background According to several studies, ROS1 rearrangement is associated with thrombotic risk in non-small cell lung cancer (NSCLC). However, there is no clear understanding of the predictors and prognostic impact of thromboembolic events (TEEs) in patients with advanced ROS1 rearrangement...

Full description

Bibliographic Details
Main Authors: Jiawen Yi, Huang Chen, Jie Li, Xingran Jiang, Yan Xu, Mengzhao Wang, Zheng Wang, Zhenguo Zhai, Yanhong Ren, Yuhui Zhang
Format: Article
Language:English
Published: BMC 2022-09-01
Series:Thrombosis Journal
Subjects:
Online Access:https://doi.org/10.1186/s12959-022-00417-8